LSB: ysbiopharm.com Company Total Sales

The potential of LakeShore Biopharma Co. (LSB) is based on margin growth during the transition to government vaccine procurement. The company's sales history confirms this trajectory, where 0.00 indicates the current level. The robotization of production lines, which eliminates human error, enhances efficiency. However, shareholder conflicts and price dumping in China create serious reputational and financial risks.

LakeShore Biopharma (LSB) Company Revenue: for the period 05/29/2024 - 10/04/2025

Analytical breakdowns for LakeShore Biopharma Co.

- stock value and consensus price forecast:

Stock Quotes YS Biopharma Co., Ltd.|LSB - Consensus Target

- market capitalization information:

Market Value LakeShore Biopharma Co., Ltd.|LSB - Enterprise Value

- book capitalization indicators:

Net Assets per Share LakeShore Biopharma|LSB - Company Book Value|Market-to-Book Ratio ysbiopharm.com|LSB - Aggregate Company Assets

- debt and solvency information:

- earnings and market multiples details:

LSB - Net Profit|Expected Net Profit LakeShore Biopharma Co.|LSB - Price to Earnings Ratio|Market Cap to Projected Earnings ysbiopharm.com|LSB - PEG Multiple|Business Value to Operating Income Before Depreciation LakeShore Biopharma Co., Ltd.|LSB - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months LakeShore Biopharma|LSB - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ysbiopharm.com|LSB - Earnings growth in current year|Expected net earnings per share growth next year LakeShore Biopharma Co.

- sales volume and revenue indicators:

LSB - Company Sales|Company Future Revenue YS Biopharma Co., Ltd.|LSB - P/S Multiple|Price-to-Projected Revenue Ratio LakeShore Biopharma Co., Ltd.

Comprehensive company analysis:YS Biopharma Co., Ltd.

This metric aggregates the actual cash inflows of the enterprise for each passing day. Such granularity allows for the filtering of market noise to identify a sustainable revenue generation trend. For LakeShore Biopharma Co. (LSB), this reflects the efficiency of vaccine sales under government contracts and the capacity utilization of bio-plants. By analyzing the sales chart of LakeShore Biopharma Co. (LSB), an investor can assess the stability of cash flow amidst stringent government regulation.

Key competitors